Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy. - Wikidata - awgldk - TriplyDB

Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.

Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.

http://www.wikidata.org/entity/Q35055089

about

Clinical utility of serum biomarkers in Duchenne muscular dystrophy Noncoding RNAs, Emerging Regulators of Skeletal Muscle Development and Diseases Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation Mega roles of microRNAs in regulation of skeletal muscle health and disease Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.MiR-206, a key modulator of skeletal muscle development and disease.Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy.How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases.Serum Levels of MicroRNA-206 and Novel Mini-STR Assays for Carrier Detection in Duchenne Muscular Dystrophy.Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine Circulating Biomarkers for Duchenne Muscular Dystrophy.Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.Drug Discovery of Therapies for Duchenne Muscular Dystrophy.Extracellular microRNAs in Membrane Vesicles and Non-vesicular Carriers.Eteplirsen: First Global Approval.Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.Reduced serum myostatin concentrations associated with genetic muscle disease progression.MicroRNA and mRNA Expression Changes in Steroid Naïve and Steroid Treated DMD Patients.Decreased myoblast differentiation in chronic binge alcohol-administered simian immunodeficiency virus-infected male macaques: role of decreased miR-206.Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration.N-terminal α Dystroglycan (αDG-N): A Potential Serum Biomarker for Duchenne Muscular Dystrophy.Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.Circulating myomiRs: a new class of biomarkers to monitor skeletal muscle in physiology and medicine.Noncoding RNAs and Duchenne muscular dystrophy.Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations.Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases.Examining the Genetic Background of Porcine Muscle Growth and Development Based on Transcriptome and miRNAome Data.Eteplirsen.

P2860

Q26751261-F7B95837-0148-4AA0-BBA3-063CA610D1AB Q26799919-24DAD335-E1DB-4DC9-8B38-02EFFB856B21 Q28271052-163C85C7-D632-4018-BF6B-746A5931216C Q28817525-F769DF65-30DA-4065-9494-A819ABE550C3 Q33810713-2176B2E7-8305-4E3B-B044-E94ED47ECA68 Q34001045-98CE7D1A-987B-482C-B954-AF6C1984C8D1 Q34555477-65EB062E-8E68-407C-B014-08CE17D2168E Q35069217-BE925D49-B38D-482B-9A37-F9743EE04247 Q35234158-5CE40AE9-1CF0-423C-92DD-9FF8063F2BE0 Q35821127-344ED6D6-FEB5-4B3E-837E-3D994074AB75 Q35937357-65D41967-9EA4-4C52-99BB-7DEDEB880672 Q35991086-E86ED566-AE69-4CD2-B247-F8073B9D3769 Q36015171-D2F7D0B1-5D09-4071-A004-7628145F13AF Q37183460-AD93288A-CF9D-4152-9ABC-61457E855177 Q37210178-0CD1BE0B-E926-4653-858C-DA0BC6717E9E Q37238936-F40354F3-9493-45D7-833D-AFBB9C2BC7A4 Q37459974-F3E3B8CB-958E-4D78-8B1B-D6AC2BEAAD42 Q37518858-5197444E-0960-41BF-8F11-4C52304192C9 Q37610530-E56C8D5E-6790-4944-BF2C-6AB262C527FE Q38302852-B85A655E-D6FD-4B68-829C-D4870CDFA346 Q38480698-A1875B69-E12E-41B6-9808-49FB4733F20C Q38648005-1D19C272-AC31-4CA9-8370-DBCEF434E724 Q38997220-2B765C03-E957-4E37-8EFC-3B796A06EBA7 Q39025668-04CCE184-CF0A-42F9-8734-C6BF56544988 Q39028061-05BA7D24-13A8-4A9F-9F9F-F56897C1DA5A Q39178174-3EF5AF9E-45D5-4E7E-9EC6-8E540DCE365E Q40150738-FC26AD36-E43E-4CF1-A215-74E03C42732B Q41104340-7E187F2A-10A1-4738-AC49-2EFF49B5F4C4 Q41228417-3D642507-DEBF-4F94-8CB9-4B11CDFB170F Q42209543-619F706E-7B11-49B0-B540-44725E1F7B00 Q42363358-ADD4E962-06A8-4709-86A4-DBC0E05B0FD9 Q47103310-92D7FD54-967D-47CB-86B7-F347205D645F Q47704855-E17812C6-563C-4022-A351-8C4B9D00AAC1 Q48543939-375A5485-8113-4C9B-8C69-07CDD23FEDD1 Q49376536-875CADF2-7801-419C-BCF4-4BCF9B7E067D Q50479884-91E0166D-E643-4832-80FA-CF86888BA334 Q51243987-8C4410CB-5670-4995-AC81-96A1F5FB0A2E Q52571235-A9D1BE87-AC1B-4033-98C2-56EC53906671 Q52719144-07E944D2-A98F-400B-A5C6-96A73E4B8E83 Q54962645-9AA47AC3-81D4-4165-80B1-84012712A52F

P2860

Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.

http://www.wikidata.org/entity/Q35055089

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@ast

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@en

type

label

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@ast

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@en

prefLabel

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@ast

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@en

P1433

Q35055089-BB65E62E-2738-4F20-9819-844A5C049A06

P1476

Q35055089-197736E8-F051-42D2-A3BD-24C538C7B01E

P2093

Q35055089-2AB4D7E8-DE56-442A-94EE-E1778D66FA26

Q35055089-464815B2-BC00-4E02-A1B8-24F0B606FBF9

Q35055089-66C2FD5F-A4EF-4051-80EB-0E5C29BB613D

Q35055089-8166EC3A-849C-43E1-9046-F3C6EBFE8015

Q35055089-8C77011C-A304-479F-A9AC-0EEC159A5751

Q35055089-9D1D07AD-FF96-4F27-8167-47B0FB950F8B

Q35055089-B0AFEDD5-2814-4FC8-9C8D-CBD0E9CE728C

Q35055089-BAE05EF8-0B9C-4D4A-A653-B7A6E978846F

Q35055089-BBBC1F6F-86AC-4805-BB98-FAEA6242B31B

Q35055089-D89CF13D-A1DE-41F5-BFA1-0B3ABB748B36

P2860

Q35055089-06202684-0B57-489D-8260-3313040AC381

Q35055089-07332CB5-B0FD-4020-88A4-91201FE47677

Q35055089-0D509FF8-D011-4AA6-BD7C-3BBA44F6809C

Q35055089-0DC71218-FCAC-44DF-8D2C-11B7A7AE5BE8

Q35055089-11BCA61C-55B1-4B86-B414-D0B35B60F525

Q35055089-16085B11-67BC-4015-AB88-2DD613F38C60

Q35055089-1DA51B14-5596-4401-8816-EF4656B7D949

Q35055089-2051EE20-1CE6-49C2-AD58-44BAD20BF9FA

Q35055089-2AE1B83B-F6E1-4F36-B60A-FAE854CEAF61

Q35055089-2E496F4B-E97B-4EC1-A94C-C243C2317CAA

P304

Q35055089-2902886B-9ED6-491D-8C5F-7119E0FDE2A2

P31

Q35055089-3192A470-8659-4A60-B469-6699F4328864

P356

Q35055089-0067E793-EFE7-4AAD-B1C3-0D9CD877B853

P407

Q35055089-61803A7F-B0D2-4B8D-A913-6DE9B73ACE85

P433

Q35055089-4628D41A-DD5B-4B31-AD5E-BC1E68AA6262

P478

Q35055089-86112640-F82E-4B90-AE43-31C92E97260D

P50

Q35055089-1C76D6F8-59B5-41A2-8400-893C721BAB73

Q35055089-7F6961B4-C1D4-4D00-B7A9-848726C9D5FC

Q35055089-9CA61D72-6B83-4E13-A3CF-671AF0E8D274

P577

Q35055089-F85B8FE7-31B8-4F1F-AAA1-647804A8B88B

P5875

Q35055089-028EA3BC-2487-4432-8F1E-206D379556B4

P698

Q35055089-BCB4B819-ADB1-4564-889F-E31ED7213058

P921

Q35055089-6FE62B59-661B-48D2-A779-35FBC07BD7A5

P932

Q35055089-12EC5D64-51FF-4B62-A2CD-754542F20098

P356

JOURNAL.PONE.0080263

P1433

P1476

Dystromirs as serum biomarkers ...... n Duchenne muscular Dystrophy.

@en

P2093

Alessandra Ferlini

http://www.w3.org/2001/XMLSchema#string

Francesco Muntoni

http://www.w3.org/2001/XMLSchema#string

Irina T Zaharieva

http://www.w3.org/2001/XMLSchema#string

James Collins

http://www.w3.org/2001/XMLSchema#string

Jennifer E Morgan

http://www.w3.org/2001/XMLSchema#string

Kate Bushby

http://www.w3.org/2001/XMLSchema#string

Lucy Feng

http://www.w3.org/2001/XMLSchema#string

Mariacristina Scoto

http://www.w3.org/2001/XMLSchema#string

Mattia Calissano

http://www.w3.org/2001/XMLSchema#string

Michela Guglieri

http://www.w3.org/2001/XMLSchema#string

P2860

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

Circulating microRNAs as stable blood-based markers for cancer detection.

Distinctive patterns of microRNA expression in primary muscular disorders

Muscle satellite cells

Dysfunction of mitochondria and sarcoplasmic reticulum in the pathogenesis of collagen VI muscular dystrophies

Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy

P304

e80263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0080263

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Mark D. Preston

P577

2013-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258956255

http://www.w3.org/2001/XMLSchema#string

P698

24282529

http://www.w3.org/2001/XMLSchema#string

P921

P932

3840009

http://www.w3.org/2001/XMLSchema#string